The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.

Saved in:
Bibliographic Details
Title: The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.
Authors: Guo, Dezhen1 (AUTHOR), Huang, Ao1 (AUTHOR), Sun, Jianlong2 (AUTHOR), Zhang, Shiyu1 (AUTHOR), Cheng, Jianwen1 (AUTHOR), Jiang, Ruijingfang2 (AUTHOR), Wang, Yupeng1 (AUTHOR), Chen, Huihao2 (AUTHOR), Zhang, Fengming2 (AUTHOR), Peng, Jiaxi2 (AUTHOR), Yuan, Jie3,4 (AUTHOR), Wang, Jiefei5 (AUTHOR), Guo, Hongying5 (AUTHOR), Chen, Zhong6 (AUTHOR), Chen, Yongjun7 (AUTHOR), Chen, Xuxiao7 (AUTHOR), Zhu, Shida2,8 (AUTHOR), Fan, Jia1 (AUTHOR), Wang, Yuying2 (AUTHOR) wangyuying@bgi.com, Yang, Xinrong1 (AUTHOR) yang.xinrong@zs-hospital.sh.cn
Source: Journal of Hematology & Oncology. 10/29/2025, Vol. 18 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-025-01747-6